Cramer’s lightning round: Hims & Hers Health is not a buy – CNBC March 17, 2022 by quixnet Cramer’s lightning round: Hims & Hers Health is not a buyCNBC Pharma will move higher, but Oppenheimer’s Holz is hesitant on valuationsCNBC Television